Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies

Clin Exp Allergy. 2023 May;53(5):582-585. doi: 10.1111/cea.14296. Epub 2023 Feb 13.

Authors

Celeste M Boesjes¹, Madelon van Emst¹, Daphne S Bakker¹, Lotte S Spekhorst¹, Femke van Wijk², Marlies de Graaf¹, Marjolein S de Bruin-Weller¹

Affiliations

¹ National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
² Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 36779570
DOI: 10.1111/cea.14296

No abstract available

Keywords: antinuclear antibodies; atopic dermatitis; autoimmunity; dupilumab; enthesitis; inflammatory arthritis.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Antinuclear / therapeutic use
Arthralgia
Dermatitis, Atopic* / drug therapy
Humans
Muscles
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Antinuclear